Abstract
The present study deals with successful utilization of both correlation and classification techniques for the development of diverse models for the prediction of dual mTOR and PI3Kα inhibitory activities using a dataset comprising of 39 analogues of 4-morpholinopyrrolopyrimidines. Decision tree, random forest, moving average analysis (MAA) and multiple linear regression (MLR) were used to develop models for mTOR and PI3Kα inhibitory activities. The proposed models were also found to be sensitive towards the cell inhibition against PC3. The models were assessed for statistical significance in terms of overall accuracy of prediction, specificity, sensitivity, Mathew’s correlation coefficient (MCC) and intercorrelation analysis. The high predictability of the proposed models of diverse nature offers enormous potential for providing lead molecules for the development of potent medicinal agents for dual mTOR and PI3Kα inhibition.
Keywords: mTOR inhibitors and PI3Kα inhibitors, 4-morpholinopyrrolopyrimidines, Topological descriptors, Decision Tree, Random forest, Moving average analysis.
Letters in Drug Design & Discovery
Title:Diverse Models for the Prediction of Dual mTOR and PI3Kα Inhibitory Activities of Substituted 4-morpholinopyrrolopyrimidines
Volume: 11 Issue: 4
Author(s): Monika Gupta and A. K. Madan
Affiliation:
Keywords: mTOR inhibitors and PI3Kα inhibitors, 4-morpholinopyrrolopyrimidines, Topological descriptors, Decision Tree, Random forest, Moving average analysis.
Abstract: The present study deals with successful utilization of both correlation and classification techniques for the development of diverse models for the prediction of dual mTOR and PI3Kα inhibitory activities using a dataset comprising of 39 analogues of 4-morpholinopyrrolopyrimidines. Decision tree, random forest, moving average analysis (MAA) and multiple linear regression (MLR) were used to develop models for mTOR and PI3Kα inhibitory activities. The proposed models were also found to be sensitive towards the cell inhibition against PC3. The models were assessed for statistical significance in terms of overall accuracy of prediction, specificity, sensitivity, Mathew’s correlation coefficient (MCC) and intercorrelation analysis. The high predictability of the proposed models of diverse nature offers enormous potential for providing lead molecules for the development of potent medicinal agents for dual mTOR and PI3Kα inhibition.
Export Options
About this article
Cite this article as:
Gupta Monika and Madan K. A., Diverse Models for the Prediction of Dual mTOR and PI3Kα Inhibitory Activities of Substituted 4-morpholinopyrrolopyrimidines, Letters in Drug Design & Discovery 2014; 11 (4) . https://dx.doi.org/10.2174/15701808113106660089
DOI https://dx.doi.org/10.2174/15701808113106660089 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH<sub>2</sub>Ph)]Br
Anti-Cancer Agents in Medicinal Chemistry Drug Combinations Enhancing the Antineoplastic Effects of Erlotinib in High-Grade Glioma
Recent Patents on Anti-Cancer Drug Discovery The Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis
Current Pharmaceutical Biotechnology Transforming Growth Factor Beta in Pancreatic Cancer
Current Pharmaceutical Biotechnology Therapeutic Potential of Resveratrol in the Treatment of Glioma: Insights into its Regulatory Mechanisms
Mini-Reviews in Medicinal Chemistry Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology
Current Pharmaceutical Design Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Current Pharmacogenomics Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression
MicroRNA Chloride Channel Expression and Functional Diversity in the Immune Cells of Allergic Diseases
Current Molecular Medicine Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells
Current Stem Cell Research & Therapy Autophagy: Molecular Mechanisms and their Implications for Anticancer Therapies
Current Cancer Drug Targets Identification of Small Molecule Sulfonic Acids as Ecto-5'-Nucleotidase Inhibitors
Medicinal Chemistry Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Artemisinin, Promising Lead Natural Product for Various Drug Developments
Mini-Reviews in Medicinal Chemistry Pharmacokinetics-Pharmacology Disconnection of Herbal Medicines and its Potential Solutions with Cellular Pharmacokinetic-Pharmacodynamic Strategy
Current Drug Metabolism Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Current Medicinal Chemistry Integrin-Mediated Drug Resistance
Current Signal Transduction Therapy NOTCH Signaling as a Novel Cancer Therapeutic Target
Current Cancer Drug Targets Advances in Biocatalytic Synthesis, Pharmacological Activities, Pharmaceutical Preparation and Metabolism of Ginsenoside Rh2
Mini-Reviews in Medicinal Chemistry Plasticity of Neuroendocrine-Immune Interactions During Ontogeny: Role of Perinatal Programming in Pathogenesis of Inflammation and Stress- Related Diseases in Adults
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery